Evidence map›Paper›PMID 26617832›Full record

ReviewInternational journal of clinical and experimental pathology2015

Tubulocystic renal cell carcinoma with poorly differentiated foci is indicative of aggressive behavior: clinicopathologic study of two cases and review of the literature.

Ming Zhao, Xiaodong Teng, Guoqing Ru, Zhongsheng Zhao, Qinqin Hu, Likai Han, Xianglei He

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2019
    Article
  7. Management of Atypical Renal Cell Carcinomas.Current treatment options in oncology · 2017
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ming ZhaoDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Xiaodong TengDepartment of Pathology, The First Affiliated Hospital, Zhejiang University College of Medicine Hangzhou 310003, Zhejiang, China.
Guoqing RuDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Zhongsheng ZhaoDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Qinqin HuDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Likai HanDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Xianglei HeDepartment of Pathology, Zhejiang Provincial People's Hospital Hangzhou 310014, Zhejiang, PR China.
Zhejiang Provincial People's Hospital · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulocystic renal cell carcinoma (TCRCC) is a rare, recently characterized RCC subtype with distinctive clinicopathologic and genetic characterizations as well as typical behaviors in an indolent fashion. However, sporadic case reports in the literature have indicated that TCRCC with sarcomatoid differentiation or poorly differentiated (PD) foci could behave aggressively. Herein, we reported two cases of TCRCC with PD foci indentified from our consultative service. Both patients were male and aged 66 y and 47 y, respectively. The first patient experienced radical nephrectomy while the other was treated by partial nephrectomy. Macroscopically, both tumors were described as partly cystic and solid with the greatest diameter measuring of 12-cm and 4.5-cm, respectively. Histologically, both lesions had classic areas of TCRCC occupying most part of the tumor with small papillary RCC component. In case one, PD foci were scatteredly distributed and mixed with TCRCC and papillary RCC components, while in the other case the PD foci were adjacent to the areas of TCRCC. In both tumors, the PD foci were composed of irregular, often angulated, small tubules lined by atypical eosinophilic cells and surrounded by desmoplastic stroma, resembling collecting duct carcinoma. Immunohistochemistry, in both tumors, both TCRCC component and PD foci showed the similar immunoprofiles, i.e., labeling strongly and diffusely with PAX8, AMACR and Vimentin, and focally with CK34βE12 but not with renal cell carcinoma marker or P63. In case one, the tumor invaded extensively into the adjacent renal parenchyma and focally into both renal sinusal and perirenal adipose tissues. The patient had metastasis in the pelvic cavity at the time of diagnosis and succumbed to the disease without further treatment 3 months later. The other case was organ confined but with focal positive renal parenchymal margin. The patient subsequently underwent radical nephrectomy and was in a good status without evidence of tumor recurrence or metastasis at a follow-up of 8 months.

Indexed as

Cell DifferentiationAgedBiomarkers, TumorBiopsyCarcinoma, Renal CellDisease ProgressionFatal OutcomeHumansImmunohistochemistryKidney NeoplasmsMaleMiddle AgedNeoplasm InvasivenessNeoplasms, Cystic, Mucinous, and SerousNephrectomyPelvic NeoplasmsBiomarkers, Tumorcollecting duct carcinomapoorly differentiated fociRCCtubulocystic carcinomaTubulocystic renal cell carcinoma

Identifiers

PMID26617832
PMCPMC4637647
OpenAlexW2191778603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.